|Bid||2.53 x 0|
|Ask||2.54 x 0|
|Day's Range||2.28 - 2.54|
|52 Week Range||0.51 - 4.18|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that recent testing with Beta 3.0 has shown the identification and first order separation of two key metabolites of ∆9-tetrahydrocannabinol (“THC”), being 11-hydroxy-delta-9-tetrahydrocannabinol and 11-nor-9-carboxy-tetrahydrocannabinol in standards. ∆9-tetrahydrocannabinol (“THC”) the main psychoactive component of marijuana is metabolized into and 11-nor-9-carboxy-tetrahydrocannabinol at different rates based on route of entry into the body. The Cannabix FAIMS device coupled to real time switchable mass spectrometry is actively being tuned to detect these key molecules and their complex pathways in the body to enable the identification of recency of use.
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering Cannabix Technologies Inc. (BLO.CN) (BLO.CN) (BLO.CN) (BLOZF) and the development of its Cannabix Marijuana Breathalyzer that aims to solve the dilemma of cannabis impairment testing with an accurate, non-invasive, portable solution that could be used by law enforcement at roadside. In an effort to bolster public safety amid concerns of cannabis-impaired driving, the state legislature introduced a bill to allow for the use of saliva tests as an alternative to the current system, which requires blood tests, a hospital visit, and a warrant. In a decision that highlights the conundrum public health officials face in regard to cannabis impairment, the Senate Judiciary Committee recently rejected the bill amid concerns of scientific validity, accuracy, and infringement on civil liberties.
SEATTLE, April 17, 2018-- CFN Media Group, the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing the complex issues ...
VANCOUVER, British Columbia, April 16, 2018-- Cannabix Technologies Inc. developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report it has filed a Patent ...